Home > Products > CD20 & CD3
> Anti-CD20 x Anti-CD3 Bispecific Antibody (IgG-IgG)
Anti-CD20 x Anti-CD3 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-051)
Anti-CD20 x Anti-CD3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD20 and anti-CD3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lymphoma therapy.
There are currently no customer reviews or questions for Anti-CD20 x Anti-CD3 Bispecific Antibody (IgG-IgG) (BSIG-051). Click the button below to contact us or submit your feedback about this product.